Drug application
NALBUPHINE HYDROCHLORIDE (NALBUPHINE HYDROCHLORIDE)
Drugs@FDA ANDA 072070 · IGI LABS INC
Key facts
| Drug name | NALBUPHINE HYDROCHLORIDE |
|---|---|
| Active ingredients | NALBUPHINE HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 072070 |
| Company | IGI LABS INC |
| Dosage forms | SOLUTION, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
| Strength | 10MG/ML (10MG/ML) |
| Marketing status | Discontinued |
| Reference listed drug | No |
At a glance
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.